These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 34663909)

  • 21. Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice.
    Kumari P; Rothan HA; Natekar JP; Stone S; Pathak H; Strate PG; Arora K; Brinton MA; Kumar M
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33477869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection.
    Han K; Blair RV; Iwanaga N; Liu F; Russell-Lodrigue KE; Qin Z; Midkiff CC; Golden NA; Doyle-Meyers LA; Kabir ME; Chandler KE; Cutrera KL; Ren M; Monjure CJ; Lehmicke G; Fischer T; Beddingfield B; Wanek AG; Birnbaum A; Maness NJ; Roy CJ; Datta PK; Rappaport J; Kolls JK; Qin X
    Am J Respir Cell Mol Biol; 2021 Jan; 64(1):79-88. PubMed ID: 32991819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Lung Mast Cells as a Possible Reservoir for Coronavirus: A Novel Unrecognized Mechanism for SARS-CoV-2 Immune-Mediated Pathology.
    Praetzel R; Kepley C
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alteration of L-Dopa decarboxylase expression in SARS-CoV-2 infection and its association with the interferon-inducible ACE2 isoform.
    Mpekoulis G; Frakolaki E; Taka S; Ioannidis A; Vassiliou AG; Kalliampakou KI; Patas K; Karakasiliotis I; Aidinis V; Chatzipanagiotou S; Angelakis E; Vassilacopoulou D; Vassilaki N
    PLoS One; 2021; 16(6):e0253458. PubMed ID: 34185793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging SARS-CoV-2 variants expand species tropism to murines.
    Shuai H; Chan JF; Yuen TT; Yoon C; Hu JC; Wen L; Hu B; Yang D; Wang Y; Hou Y; Huang X; Chai Y; Chan CC; Poon VK; Lu L; Zhang RQ; Chan WM; Ip JD; Chu AW; Hu YF; Cai JP; Chan KH; Zhou J; Sridhar S; Zhang BZ; Yuan S; Zhang AJ; Huang JD; To KK; Yuen KY; Chu H
    EBioMedicine; 2021 Nov; 73():103643. PubMed ID: 34689086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.
    Pantazi I; Al-Qahtani AA; Alhamlan FS; Alothaid H; Matou-Nasri S; Sourvinos G; Vergadi E; Tsatsanis C
    Front Immunol; 2021; 12():683800. PubMed ID: 34248968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCR2 Signaling Restricts SARS-CoV-2 Infection.
    Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
    mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2.
    Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
    Cells; 2021 Jun; 10(6):. PubMed ID: 34201214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Receptor utilization of angiotensin-converting enzyme 2 (ACE2) indicates a narrower host range of SARS-CoV-2 than that of SARS-CoV.
    Wang Q; Qiu Y; Li JY; Liao CH; Zhou ZJ; Ge XY
    Transbound Emerg Dis; 2021 May; 68(3):1046-1053. PubMed ID: 32794346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice.
    Paull JRA; Luscombe CA; Castellarnau A; Heery GP; Bobardt MD; Gallay PA
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species.
    Zhang HL; Li YM; Sun J; Zhang YY; Wang TY; Sun MX; Wang MH; Yang YL; Hu XL; Tang YD; Zhao J; Cai X
    J Biol Chem; 2021; 296():100435. PubMed ID: 33610551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.
    Gralinski LE; Sheahan TP; Morrison TE; Menachery VD; Jensen K; Leist SR; Whitmore A; Heise MT; Baric RS
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An
    Pechous RD; Malaviarachchi PA; Banerjee SK; Byrum SD; Alkam DH; Ghaffarieh A; Kurten RC; Kennedy JL; Zhang X
    J Virol; 2024 Jul; 98(7):e0079424. PubMed ID: 38940558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective Effects of Necrostatin-1 in Acute Pancreatitis: Partial Involvement of Receptor Interacting Protein Kinase 1.
    Ouyang Y; Wen L; Armstrong JA; Chvanov M; Latawiec D; Cai W; Awais M; Mukherjee R; Huang W; Gough PJ; Bertin J; Tepikin AV; Sutton R; Criddle DN
    Cells; 2021 Apr; 10(5):. PubMed ID: 33925729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imatinib (STI571) Inhibits the Expression of Angiotensin-Converting Enzyme 2 and Cell Entry of the SARS-CoV-2-Derived Pseudotyped Viral Particles.
    Lin YZ; Shen YC; Wu WR; Wang WJ; Wang YL; Lin CY; Hung MC; Wang SC
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
    Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S
    Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population-Specific
    Hashizume M; Gonzalez G; Ono C; Takashima A; Iwasaki M
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33418950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries.
    David AB; Diamant E; Dor E; Barnea A; Natan N; Levin L; Chapman S; Mimran LC; Epstein E; Zichel R; Torgeman A
    Molecules; 2021 May; 26(11):. PubMed ID: 34072087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
    Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
    Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of Unique Pathological Features of COVID-Associated Coagulopathy: Studies with AC70 hACE2 Transgenic Mice Highly Permissive to SARS-CoV-2 Infection.
    Drelich AK; Rayavara K; Hsu J; Saenkham-Huntsinger P; Judy BM; Tat V; Ksiazek TG; Peng BH; Tseng CK
    PLoS Pathog; 2024 Jun; 20(6):e1011777. PubMed ID: 38913740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.